Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-08-28 Purchase |
2020-09-01 9:34 pm |
Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO 10% Owner |
8,488 | $5.84 | $49,570 | 5,827,991 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2020-12-17 Option Award |
2020-12-21 4:34 pm |
N/A 2030-12-16 |
Ovid Therapeutics Inc. | OVID | Daly Timothy EVP,Finance & Corp. Controller |
125,000 | $0 | 125,000 (Direct) |
View |
2020-10-11 Option Award |
2020-10-13 4:46 pm |
N/A 2030-10-10 |
Ovid Therapeutics Inc. | OVID | Rona Jeffrey A Chief Business Officer |
20,000 | $0 | 20,000 (Direct) |
View |
2020-10-11 Option Award |
2020-10-13 4:41 pm |
N/A 2030-10-10 |
Ovid Therapeutics Inc. | OVID | Haasner Dirk SVP, Global Regulatory Affairs |
20,000 | $0 | 20,000 (Direct) |
View |
2020-10-11 Option Award |
2020-10-13 4:38 pm |
N/A 2030-10-10 |
Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary |
20,000 | $0 | 20,000 (Direct) |
View |
2020-09-30 Option Award |
2020-10-02 9:40 pm |
N/A 2030-09-29 |
Ovid Therapeutics Inc. | OVID | Rona Jeffrey A Chief Business Officer |
325,000 | $0 | 325,000 (Direct) |
View |